Clinical Trials Browser

OTHER × Adenocarcinoma × regorafenib × Clear all

NCT03722108 2023-10-16

REGIRI

Phase 1/2 Terminated

Adenocarcinoma

NCT01929616 2019-06-25

RegARd-C

Phase 2 Completed

Adenocarcinoma